Prostaglandins in heart transplantation.
Iberer
F
F
Department of Surgery, Karl-Franzens-University of Graz, Austria.
Wasler
A
A
Petutschnigg
B
B
Müller
H
H
Allmayer
T
T
Grasser
B
B
Prenner
G
G
Schaffellner
S
S
Hipmayr
G
G
Tscheliessnigg
K H
KH
D000527:Alprostadil / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy / Q000503:physiopathology; D016027:Heart Transplantation / Q000502:physiology*; D006353:Heart-Assist Devices; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011183:Postoperative Complications; D011652:Pulmonary Circulation; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000627:therapeutic use*; D018497:Ventricular Dysfunction, Right / Q000188:drug therapy
D007166:Immunosuppressive Agents; D014665:Vasodilator Agents; D016572:Cyclosporine; D000527:Alprostadil